Please wait
false --12-31 2025 Q2 0000888981 0000888981 2025-01-01 2025-06-30 0000888981 2025-08-06 0000888981 2025-04-01 2025-06-30 0000888981 2024-04-01 2024-06-30 0000888981 2024-01-01 2024-06-30 0000888981 2025-06-30 0000888981 2024-12-31 0000888981 2023-12-31 0000888981 2024-06-30 0000888981 us-gaap:CommonStockMember 2024-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000888981 us-gaap:RetainedEarningsMember 2024-12-31 0000888981 us-gaap:CommonStockMember 2025-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000888981 us-gaap:RetainedEarningsMember 2025-03-31 0000888981 2025-03-31 0000888981 us-gaap:CommonStockMember 2023-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000888981 us-gaap:RetainedEarningsMember 2023-12-31 0000888981 us-gaap:CommonStockMember 2024-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000888981 us-gaap:RetainedEarningsMember 2024-03-31 0000888981 2024-03-31 0000888981 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000888981 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000888981 2025-01-01 2025-03-31 0000888981 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000888981 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000888981 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000888981 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000888981 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000888981 2024-01-01 2024-03-31 0000888981 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000888981 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000888981 us-gaap:CommonStockMember 2025-06-30 0000888981 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000888981 us-gaap:RetainedEarningsMember 2025-06-30 0000888981 us-gaap:CommonStockMember 2024-06-30 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000888981 us-gaap:RetainedEarningsMember 2024-06-30 0000888981 us-gaap:RestrictedStockUnitsRSUMember nnup:N2024PlanMember 2025-01-01 2025-06-30 0000888981 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000888981 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0000888981 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-06-30 0000888981 us-gaap:CommonStockMember 2024-08-18 0000888981 nnup:N2024PlanMember nnup:ReplacementGrantMember 2024-08-15 2024-08-16 0000888981 nnup:ReplacementGrantMember 2024-08-16 0000888981 nnup:ReplacementGrantMember 2024-12-22 2024-12-23 0000888981 nnup:ReplacementGrantMember 2024-12-23 0000888981 nnup:PNCBankMember 2025-06-30 0000888981 2024-01-01 2024-12-31 0000888981 2023-09-10 2023-09-11 0000888981 us-gaap:PrivatePlacementMember 2023-09-10 2023-09-11 0000888981 us-gaap:PrivatePlacementMember 2023-09-11 0000888981 2023-09-11 0000888981 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2024-12-21 2024-12-24 0000888981 2024-12-24 0000888981 us-gaap:DomesticCountryMember 2025-06-30 0000888981 us-gaap:DomesticCountryMember 2024-12-31 0000888981 us-gaap:StateAndLocalJurisdictionMember 2025-06-30 0000888981 us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000888981 2025-01-02 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerAMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerAMember 2024-04-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerAMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerAMember 2024-01-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerBMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerBMember 2024-04-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerBMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerBMember 2024-01-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerCMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerCMember 2024-04-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerCMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember nnup:CustomerCMember 2024-01-01 2024-06-30 0000888981 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember nnup:CustomerAMember 2025-01-01 2025-06-30 0000888981 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember nnup:CustomerAMember 2024-01-01 2024-12-31 0000888981 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember nnup:CustomerBMember 2025-01-01 2025-06-30 0000888981 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember nnup:CustomerBMember 2024-01-01 2024-12-31 0000888981 srt:NorthAmericaMember 2025-04-01 2025-06-30 0000888981 srt:NorthAmericaMember 2024-04-01 2024-06-30 0000888981 srt:NorthAmericaMember 2025-01-01 2025-06-30 0000888981 srt:NorthAmericaMember 2024-01-01 2024-06-30 0000888981 srt:SouthAmericaMember 2025-04-01 2025-06-30 0000888981 srt:SouthAmericaMember 2024-04-01 2024-06-30 0000888981 srt:SouthAmericaMember 2025-01-01 2025-06-30 0000888981 srt:SouthAmericaMember 2024-01-01 2024-06-30 0000888981 srt:AsiaMember 2025-04-01 2025-06-30 0000888981 srt:AsiaMember 2024-04-01 2024-06-30 0000888981 srt:AsiaMember 2025-01-01 2025-06-30 0000888981 srt:AsiaMember 2024-01-01 2024-06-30 0000888981 country:AU 2025-04-01 2025-06-30 0000888981 country:AU 2024-04-01 2024-06-30 0000888981 country:AU 2025-01-01 2025-06-30 0000888981 country:AU 2024-01-01 2024-06-30 0000888981 2024-05-01 0000888981 nnup:LicensesRoyaltiesAndFeesMember 2025-04-01 2025-06-30 0000888981 nnup:LicensesRoyaltiesAndFeesMember 2024-04-01 2024-06-30 0000888981 nnup:LicensesRoyaltiesAndFeesMember 2025-01-01 2025-06-30 0000888981 nnup:LicensesRoyaltiesAndFeesMember 2024-01-01 2024-06-30 0000888981 nnup:ProductandOtherSalesMember 2025-04-01 2025-06-30 0000888981 nnup:ProductandOtherSalesMember 2024-04-01 2024-06-30 0000888981 nnup:ProductandOtherSalesMember 2025-01-01 2025-06-30 0000888981 nnup:ProductandOtherSalesMember 2024-01-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember nnup:InternationallyMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember nnup:InternationallyMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2024-04-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2024-01-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember nnup:InternationallyMember 2024-04-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember nnup:InternationallyMember 2024-01-01 2024-06-30 0000888981 us-gaap:SalesRevenueNetMember nnup:MajorCustomersMember nnup:TwoCustomersMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember nnup:MajorCustomersMember nnup:TwoCustomersMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember nnup:MajorCustomersMember nnup:ThreeCustomerMember 2025-04-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember nnup:MajorCustomersMember nnup:ThreeCustomerMember 2025-01-01 2025-06-30 0000888981 us-gaap:SalesRevenueNetMember nnup:TwoCustomersMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000888981 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember nnup:TwoCustomersMember 2024-04-01 2024-06-30 0000888981 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember nnup:TwoCustomersMember 2024-01-01 2024-06-30 0000888981 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember nnup:TwoCustomersMember 2024-01-01 2024-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

Form 10-Q

(Mark One)

 

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended June 30, 2025

 

or

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from ____________ to ______________

 

Commission File Number: 000-20333

 

NOCOPI TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Maryland  87-0406496
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

 

480 Shoemaker Road, Suite 104, King of Prussia, PA 19406

(Address of principal executive offices) (Zip Code)

 

(610) 834-9600

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer    Accelerated filer   
Non-accelerated filer      Smaller reporting company  
  Emerging growth company  

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 10,792,913 shares of common stock, par value $0.01, as of August 6, 2025.

 

 

 
 

 

 

NOCOPI TECHNOLOGIES, INC.

 

INDEX

 

  PAGE
Part I. FINANCIAL INFORMATION  
   
Item 1.      Financial Statements 1
   
Statements of Comprehensive Loss for Three and Six Months Ended June 30, 2025 and June 30, 2024 1
Balance Sheets at June 30, 2025 and December 31, 2024 2
Statements of Cash Flows for Six Months Ended June 30, 2025 and June 30, 2024 3
Statements of Stockholders’ Equity for Three and Six Months Ended June 30, 2025 and June 30, 2024 4
Notes to Financial Statements 5
   
Item 2.      Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
   
Item 3.      Quantitative and Qualitative Disclosures About Market Risk 18
   
Item 4.      Controls and Procedures 18
   
Part II. OTHER INFORMATION  
   
Item 1.       Legal Proceedings 19
   
Item 1A.   Risk Factors 19
   
Item 2.       Unregistered Sales of Equity Securities and Use of Proceeds. 19
   
Item 3.      Defaults Upon Senior Securities 19
   
Item 4.      Mine Safety Disclosures 19
   
Item 5.      Other Information 19
   
Item 6.      Exhibits 19
   
SIGNATURES 20
   

 

 i

 
 

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Nocopi Technologies, Inc.

Statements of Comprehensive Loss*

(unaudited)

                 
   Three Months ended
June 30
   Six Months ended
June 30
 
   2025   2024   2025   2024 
Revenues                
Licenses, royalties and fees  $140,100   $89,000   $330,400   $175,500 
Product and other sales   219,900    370,000    508,600    681,800 
Total revenues   360,000    459,000    839,000    857,300 
                     
Cost of revenues                    
Licenses, royalties and fees   39,100    51,000    82,600    102,700 
Product and other sales   129,400    177,700    291,200    358,700 
Total cost of revenues   168,500    228,700    373,800    461,400 
Gross profit   191,500    230,300    465,200    395,900 
                     
Operating expenses                    
Research and development   43,200    42,100    88,200    83,500 
Sales and marketing   57,300    75,900    148,300    144,900 
General and administrative   263,500    1,254,700    487,000    2,469,500 
Total operating expenses   364,000    1,372,700    723,500    2,697,900 
Net loss from operations   (172,500)   (1,142,400)   (258,300)   (2,302,000)
                     
Other income (expenses)                    
Interest income   120,000    142,800    237,200    279,900 
Interest expense and bank charges   (6,100)   (5,800)   (12,000)   (11,500)
Total other income (expenses)   113,900    137,000    225,200    268,400 
Net loss before income taxes   (58,600)   (1,005,400)   (33,100)   (2,033,600)
Income taxes                
Net loss  $(58,600)  $(1,005,400)  $(33,100)  $(2,033,600)
                     
Net loss per common share                    
Basic and diluted  $(.01)  $(.10)  $(.003)  $(.19)
                     
Weighted average common shares outstanding                    
Basic and diluted   10,792,913    10,501,178    10,792,913    10,501,178 

 

See accompanying notes to these condensed financial statements.

 

 

1 
 

 

 

Nocopi Technologies, Inc.

Balance Sheets*

 (unaudited)

         
 
 
 
 
June 30
2025
 
 
 
 
December 31
2024
 
 
Assets
Current assets          
Cash  $11,295,000   $10,839,700 
Accounts receivable less $12,000 allowance for credit losses   1,134,000    1,234,500 
Inventory, net of allowance of $86,500 and $85,400   372,200    349,600 
Prepaid and other   113,800    155,700 
Total current assets   12,915,000    12,579,500 
           
Fixed assets          
Leasehold improvements   81,500    81,500 
Furniture, fixtures and equipment   179,700    179,700 
 Fixed assets, gross   261,200    261,200 
Less: accumulated depreciation and amortization   247,900    244,500 
 Total fixed assets   13,300    16,700 
           
Other assets          
Long-term receivable   1,073,500    1,292,800 
Operating lease right of use – building   198,400    32,400 
 Total other assets   1,271,900    1,325,200 
Total assets  $14,200,200   $13,921,400 
           
Liabilities and Stockholders' Equity          
           
Current liabilities          
Accounts payable  $107,600   $20,900 
Accrued expenses   130,800    108,300 
Stock compensation payable   70,300    26,800 
Operating lease liability – current   129,400    35,200 
Total current liabilities   438,100    191,200 
           
Long-term liabilities          
Accrued expenses – non-current   75,100    90,400 
Operating lease liability – non-current   76,200     
 Total liabilities   589,400    281,600 
           
Stockholders' equity          

Common stock, $0.01 par value

Authorized – 75,000,000 shares

Issued and outstanding – 10,792,913 shares 

   107,900    107,900 
Paid-in capital   25,584,500    25,580,400 
Accumulated deficit   (12,081,600)   (12,048,500)
Total stockholders' equity   13,610,800    13,639,800 
Total liabilities and stockholders' equity  $14,200,200   $13,921,400 

 

 

*See accompanying notes to these condensed financial statements.

 

 

2 
 

 

  

Nocopi Technologies, Inc.

Statements of Cash Flows*

(unaudited)

 

         
   Six Months ended
June 30
 
   2025   2024 
Operating Activities          
Net loss  $(33,100)  $(2,033,600)
Adjustments to reconcile net loss to net cash provided by operating activities          
Depreciation and amortization   3,400    21,700 
Stock-based compensation   47,600    1,823,900 
Amortization of operating lease right of use-building   38,500    17,600 
Inventory reserve   1,100    (59,200)
(Increase) decrease in assets          
Accounts receivable   100,500    22,300 
Inventory   (23,700)   187,900 
Interest receivable       (92,300)
Prepaid and other current assets   41,900    17,000 
Long-term receivables   219,300    203,300 
Increase (decrease) in liabilities          
Accounts payable   86,700    72,700 
Accrued expenses   7,200    20,400 
Operating lease liability-current   (34,100)   53,000 
Taxes on income        
Net cash provided by operating activities   455,300    254,700 
           
Investing Activities          
Additions to fixed assets       (8,700)
Sale of short-term investment       2,162,600 
Net cash provided by investing activities       2,153,900 
           
           
Increase in cash and cash equivalents   455,300    2,408,600 
           
Cash and Cash Equivalents          
  Beginning of year   10,839,700    2,269,200 
  End of period  $11,295,000   $4,677,800 
           
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
    Right of use asset and liability  $204,500   $ 

 

 

*See accompanying notes to these condensed financial statements.

  

 

3 
 

 

 

Nocopi Technologies, Inc.

Statements of Stockholders’ Equity*

For the Three and Six Months ended June 30, 2025 and June 30, 2024

(unaudited)

 

                     
   Common stock   Paid-in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance at December 31, 2024   10,792,913   $107,900   $25,580,400   $(12,048,500)  $13,639,800 
Stock-based compensation           2,000        2,000 
Net income               25,500    25,500 
Balance at March 31, 2025   10,792,913    107,900    25,582,400    (12,023,500)   13,667,300 
Stock-based compensation           2,100        2,100 
Net loss               (58,600)   (58,600)
Balance at June 30, 2025   10,792,913   $107,900   $25,584,500   $(12,081,600)  $13,610,800 

 

   Common stock   Paid-in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance at December 31, 2023   10,501,178   $105,000   $21,647,100   $(9,369,600)  $12,382,500 
Net loss               (1,028,200)   (1,028,200)
Balance at March 31, 2024   10,501,178    105,000    21,647,100    (10,397,800)   11,354,300 
Net loss               (1,005,400)   (1,005,400)
Balance at June 30, 2024   10,501,178   $105,000   $21,647,100   $(11,403,200)  $10,348,900 

 

 

* See accompanying notes to these condensed financial statements.

 

 

4 
 

 

  

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

Note 1. Financial Statements

 

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (the “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in Note 2 Significant Accounting Policies included in the notes to financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on March 25, 2025 (the “2024 Annual Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The notes to financial statements included in the 2024 Annual Report should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months and six months ended June 30, 2025 may not be necessarily indicative of the operating results expected for the full year.

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income (loss).  Comprehensive income (loss) is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income (loss).  Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

 

Reclassifications

 

Certain reclassifications have been made to the 2024 financial statements in order to conform to the 2025 financial statement presentation. There was no impact to the Company’s 2024 net loss.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740). The amendments in this Update related to the rate reconciliation and income taxes paid disclosures improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The amendments allow investors to better assess, in their capital allocation decisions, how an entity’s worldwide operations and related tax risks and tax planning and operational opportunities affect its income tax rate and prospects for future cash flows. The other amendments in this Update improve the effectiveness and comparability of disclosures by (1) adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with U.S. Securities and Exchange Commission (SEC) Regulation S-X 210.4-08(h), Rules of General Application—General Notes to Financial Statements: Income Tax Expense, and (2) removing disclosures that no longer are considered cost beneficial or relevant. For public business entities, the amendments in this Update are effective for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied on a prospective basis. Retrospective application is permitted. We are evaluating the effect that this guidance will have on our consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03). The new guidance requires disaggregated information about certain income statement expense line items on an annual and interim basis. This guidance will be effective for annual periods beginning the year ended December 31, 2027 and for interim periods thereafter. The new standard permits early adoption and can be applied prospectively or retrospectively. We are evaluating the effect that this guidance will have on our consolidated financial statements and related disclosures.

5 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose significant segment expenses and other segment items on an interim and annual basis and provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The ASU does not change how a public entity identifies its operating segments, aggregates them, or applies the quantitative threshold to determine its reportable segments. The new disclosure requirements are also applicable to entities that account and report as a single operating segment entity. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company adopted the guidance for the annual reporting period ended December 31, 2024. There was no impact on the Company’s reportable segments identified and additional required disclosures have been included in Note 11 - Segment Reporting.

Note 2. Stock Based Compensation

 

The Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. On June 17, 2024, the Company’s shareholders approved the Nocopi Technologies, Inc. 2024 Incentive Compensation Plan (the “2024 Plan”), which allows the Company to issue equity awards to directors, officers, other employees and consultants of the Company. As of June 30, 2025, 5,000 unvested restricted stock units (“RSUs”) are outstanding under the 2024 Plan. In addition, as of June 30, 2025, 149,805 shares have been issued in settlement of vested RSUs granted under the 2024 Plan. As of June 30, 2025, the unamortized value related to grants under the 2024 Plan was $4,000.

 

As part of an employment agreement, the Company granted (the “Prior Grant”) to an executive a one-time equity award of 1,000,000 RSUs valued at $3,580,000, fair value, which award was originally set to vest in its entirety on August 18, 2024. The fair market value of the restricted stock award was determined based on the closing price of the Company’s common stock on the grant date and was expensed on a straight-line basis to general and administrative expense as stock-based compensation over the one-year vesting term. The Company recorded stock-based compensation expense of $890,100 and $1,780,200 for the three and six months ended June 30, 2024. Under the original terms of the award, to the extent the Company had not established an employee equity compensation plan on or prior to August 18, 2024, the RSUs may have been converted, at the election of the executive, in full or in part, into cash compensation, at a rate of $3.58 per share of common stock, which was the fair market value of the common stock on October 10, 2023, which was the date the Board of Directors approved the grant. Since the issuance of the RSUs can be settled in cash, the monthly expense was credited to a liability account, stock compensation liability, instead of equity.

 

On August 16, 2024, the executive agreed to cancel and forfeit the Prior Grant and, in lieu of the Prior Grant, the Company granted the executive 1,649,769 RSUs (“Replacement Grant”), pursuant to and subject to the 2024 Plan and an award agreement, as approved by the Board of Directors. The fair market value of the replacement grant was $3,580,000, which was determined based on the closing price of the Company’s common stock on the grant date. The shares of common stock underlying the Replacement Grant shall vest ratably and quarterly over a two-year period beginning on the Replacement Grant date, August 16, 2024. The cancellation and issuance of the Replacement Grant is treated as a modification of an award under FASB ASC 718. This modification resulted in an incremental fair value of $1,410,000, calculated as the difference between the fair value of the Replacement Grant and the fair value of the Prior Grant on the modification date. The incremental fair value will be recognized as additional compensation expense on a straight-line basis over the new two-year vesting period. The Company will relieve the stock compensation liability on a proportional basis as the Replacement Grant vests. On December 23, 2024, the executive agreed to forfeit to the Company all remaining 1,443,548 shares underlying the unvested RSUs outstanding under the Replacement Grant. The fair market value of $3,132,500 was recorded as a credit to equity and a debit to stock compensation payable. The RSUs were excluded from the diluted earnings per share as their effect was anti-dilutive for the periods presented.

 

 

6 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

 

Note 3. Cash and Cash Equivalents

        
  

June 30

2025

  

December 31

2024

 
Cash and cash equivalents          
  Cash and money market funds  $11,295,000   $10,839,700 
 Cash and cash equivalents  $11,295,000   $10,839,700 

   

Cash deposits exceeding federally insured limits are subject to credit risk. The Company maintains its cash and cash equivalents primarily with PNC Bank, which are insured by the FDIC up to $250,000. At June 30, 2025 and December 31, 2024, the Company had $11,045,000 and $10,589,700 in excess of the FDIC insured limit, respectively.

 

Note 4. Inventories 

        
   June 30
2025
   December 31
2024
 
Inventories consist of the following          
Raw materials  $452,600   $428,000 
Work In Process   6,100     
Finished goods       7,000 
Inventory gross   458,700    435,000 
Less: Allowance   (86,500)   (85,400)
Inventory  $372,200   $349,600 

 

Note 5. Long-term Receivables

 

As of June 30, 2025 and December 31, 2024, the Company had long-term receivables of $1,073,500 and $1,292,800, respectively, from four and two licensees, respectively, representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the fourth quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with three existing licensees and a license agreement with a new licensee. The receivable represents the present value of the fixed minimum annual payments due under the license agreements, discounted at the Company's incremental borrowing rate of 6.32% for two licensees that renewed in 2022 and 8.14% for a licensee that renewed in January 2025 and new licensee in June 2025. 

 

The four agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

 

  · The royalty payment is fixed or determinable

 

  · Collection of the royalty payment is considered probable

 

  · The licensee has the ability to benefit from the licensed technology

 

The Company determined that the above conditions were met upon execution of the four license agreements. The commissions are payable over the term of the license agreements and are due when payments are received by the Company. As of June 30, 2025 and December 31, 2024, the accrued commission payable balance was $116,900 and $128,500, respectively, included on the balance sheet in accrued expenses and accrued expenses, non-current.

 

The current portion of the license agreements in the amount of $597,200 and $545,700, is included in accounts receivable on the balance sheets as of June 30, 2025 and December 31, 2024, respectively.

 

 

7 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

 

The following table summarizes the future minimum payments due under the four license agreements as of June 30, 2025:

     
Year Ending December 31:     
 2025   $310,000 
 2026    634,000 
 2027    567,500 
 2028    270,000 
    Total   $1,781,500 

 

The Company has evaluated the collectability of the long-term receivables and believes them to be fully collectible as of June 30, 2025. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors. 

 

The long-term receivables are recorded at its present value as of June 30, 2025, and the receivable and imputed interest will be amortized over the term of the license agreements using the effective interest method. The book value approximates the fair value for long-tern receivables. The unamortized balance of the long-term receivables as of June 30, 2025 and December 31, 2024 was $1,073,500 and $1,292,800, respectively. The unamortized imputed interest balance as of June 30, 2025 and December 31, 2024 was $102,900 and $110,500, respectively, which will be recognized as interest income through December 31, 2028. Interest income derived from long-term receivables was $5,500 and $3,700 for the three months ended June 30, 2025 and 2024, respectively, and $10,500 and $6,900 for the six months ended June 30, 2025 and 2024, respectively, included in the statements of comprehensive income (loss).  

  

Note 6. Stockholders’ Equity

On September 11, 2023, the Company entered into a stock purchase agreement in connection with a private placement for total gross proceeds of $5.0 million. The stock purchase agreement provided for the issuance of an aggregate of 1,250,000 shares of the Company’s common stock to an investor at a purchase price of $4.00 per share. On September 11, 2023, the sale pursuant to the Purchase Agreement closed. No placement fees or commissions were paid in connection with this transaction. In addition, as consideration for general advisory services until the third anniversary, the Company agreed to issue an aggregate total of 65,790 shares of common stock with a total fair market value on the date of grant of $263,160, which shares shall be issued as follows: one-third (21,930 shares) on September 11, 2024, which was issued on such date, one-third (21,930 shares) on September 11, 2025 and one-third (21,930 shares) on September 11, 2026. The Company expenses the value of the stock grant, which is determined to be the fair market value of the shares at the date of grant, straight-line over the term of the advisory agreement. For the three months ended June 30, 2025 and 2024, the Company recognized $21,800 and $21,800, respectively, of consulting expense associated with this issuance. For the six months ended June 30, 2025 and 2024, the Company recognized $43,500 and $43,700, respectively, of consulting expense associated with this issuance. On September 11, 2024, the Company issued 21,930 shares of its common stock for advisory services upon the vesting of the first tranche described above with a fair value of $87,700. As of June 30, 2025, the unamortized value related to the grant for advisory services was $105,200.

On December 24, 2024, an executive of the Company was granted 10,000 RSUs, of which 5,000 RSU’s vested on December 24, 2024 and the remaining 5,000 RSUs vest on December 24, 2025, with a total fair market value on date of grant of $16,700 of which $8,350 was vested. The Company expenses the value of the stock grant, which is determined to be the fair market value of the non-vested shares at the date of grant, straight-line over the vesting period. For the three and six months ended June 30, 2025 , the Company recognized $2,100 and $4,100, respectively, of stock-based compensation expense. For the three and six months ended June 30, 2024, the Company recognized $0 of stock-based compensation expense.

8 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

Note 7. Income Taxes

 

There was no income tax expense reflected in the results of operations for the quarter ended June 30, 2025 and 2024 and the year ended December 31, 2024, because the Company utilized net operating loss carryforwards.

 

As of June 30, 2025 and December 31, 2024, the Company had federal net operating loss carry forwards of $647,000 and $707,000, respectively, and state net operating loss carryforwards of $2,501,000 and $2,568,000, respectively, which may be used to offset future taxable income. The remaining federal NOL's will not expire but will be limited to 80% of taxable income. The Pennsylvania NOL's began to expire in 2024, with $1,307,000 expiring by 2032. The remaining Pennsylvania NOL's expire in 20 years and the Florida NOL's will not expire.

 

The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2025, the Company had no unrecognized tax benefits, or any tax related interest or penalties, and it does not expect significant changes in the amount of unrecognized tax benefits to occur within the next twelve months. There were no changes in the Company’s unrecognized tax benefits during the six-month period ended June 30, 2025. The Company did not recognize any interest or penalties during 2025 related to unrecognized tax benefits.

 

With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31, 2022 and thereafter are subject to examination by the relevant taxing authorities. Net operating loss (NOL) carryforwards are subject to examination in the year they are utilized regardless of whether the tax year in which they are generated has been closed by the statute. The amount subject to disallowance is limited to the NOL utilized. Accordingly, the company may be subject to examination for prior NOLs generated as such NOLs are utilized.

 

Note 8. Earnings (Loss) per Share

 

In accordance with FASB ASC 260, Earnings per Share, basic earnings (loss) per common share is computed using net earnings (loss) divided by the weighted average number of common shares outstanding for the periods presented. Diluted earnings (loss) per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Since the Company did not have any common stock equivalents outstanding as of June 30, 2025 and June 30, 2024, basic and diluted earnings (loss) per share were the same. 

 

Note 9. Major Customer and Geographic Information

 

The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:

                
  

Three Months ended

June 30

  

Six Months ended

June 30

 
   2025   2024   2025   2024 
Customer A   58%   69%   54%   69%
Customer B   24%   14%   17%   15%
Customer C           12%    

 

The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

        
   June 30   December 31 
   2025   2024 
Customer A   13%   15%
Customer B   76%   78%

 

The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company’s business operations and financial condition.

 

9 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

The Company’s revenues by geographic region are as follows:

                       
   

Three Months ended

June 30

   

Six Months ended

June 30

 
    2025     2024     2025     2024  
North America   $ 136,600     $ 87,300     $ 321,700     $ 165,000  
South America           600             600  
Asia     210,200       357,300       482,400       659,300  
Australia     13,200       13,800       34,900       32,400  
    $ 360,000     $ 459,000     $ 839,000     $ 857,300  

 

Note 10. Leases

 

The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring on December 31, 2027.

 

The Company entered into a second amendment to the operating lease agreement, relating to the leased facilities. The second amendment provides for an extension term to December 31, 2027, and for monthly rent payments of, initially, $7,147.00, escalating annually by 3.5%. The second amendment became effective on June 1, 2025.

 

The Company has capitalized the present value of the minimum lease payments commencing June 1, 2025, using an estimated incremental borrowing rate of 6.5%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

 

As of June 30, 2025 and December 31, 2024, the operating lease asset amounted to $198,400 and $32,400, respectively, and operating lease liability amounted to $205,600 and $35,200, respectively.

There are no other material operating leases. The Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

 

Total operating lease costs were $20,400 and $40,000 for the three and six months ended June 30, 2025, respectively, and $17,600 and $31,000 for the three and six months ended June 30, 2024, respectively.

 

Undiscounted future minimum lease payments as of June 30, 2025, by year and in aggregate are as follows:

 

     
     Operating Leases 
 Year ending December 31      
 2025   $42,900 
 2026    88,700 
 2027    91,900 
 Total lease payments    223,500 
 Less imputed interest    (17,900)
 Total   $205,600 

 

 

 

10 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

 Note 11. Segment Reporting

 

The Company operates as a single reportable segment, as the Chief Operating Decision Maker (“CODM”), the Chief Executive Officer (“CEO”), evaluates the business on a consolidated basis and does not receive discrete financial information for multiple business units.

 

Measure of Segment Profit or Loss

 

The CODM assesses the Company’s financial performance based on operating loss, which aligns with the amount reported in the statement of comprehensive loss. The following table presents a reconciliation of segment operating loss to net loss:  

 

 

                    
   Three Months ended
June 30
   Six Months ended
June 30
 
   2025   2024   2025   2024 
Revenues                
Licenses, royalties and fees  $140,100   $89,000   $330,400   $175,500 
Product and other sales   219,900    370,000    508,600    681,800 
Total revenues   360,000    459,000    839,000    857,300 
                     
Cost of revenues                    
Licenses, royalties and fees   39,100    51,000    82,600    102,700 
Product and other sales   129,400    177,700    291,200    358,700 
Total cost of revenues   168,500    228,700    373,800    461,400 
Gross profit   191,500    230,300    465,200    395,900 
                     
Operating expenses                    
Research and development   43,200    42,100    88,200    83,500 
Sales and marketing   57,300    75,900    148,300    144,900 
General and administrative   263,500    1,254,700    487,000    2,469,500 
Total operating expenses   364,000    1,372,700    723,500    2,697,900 
Net income (loss) from operations   (172,500)   (1,142,400)   (258,300)   (2,302,000)
                     
Other income (expenses)                    
Interest income   120,000    142,800    237,200    279,900 
Interest expense and bank charges   (6,100)   (5,800)   (12,000)   (11,500)
Total other income (expenses)   113,900    137,000    225,200    268,400 
Net income (loss) before income taxes   (58,600)   (1,005,400)   (33,100)   (2,033,600)
Income taxes                
Net income (loss)  $(58,600)  $(1,005,400)  $(33,100)  $(2,033,600)

 

Significant Segment Expenses

 

The Company considers the following as significant expenses in evaluating its segment performance:

 

  · Research and Development: includes costs related to personnel, laboratory materials and supplies and product development and testing for ink technologies.

 

  · General and Administrative: includes personnel costs, professional fees, and other overhead expenses.

 

  · Sales and Marketing: includes personnel costs and other sales related expenses.

 

  · Cost of Revenues: represents labor costs, material costs and manufacturing overhead costs associated with the production of materials transferred to the customer from the Company’s facility.

 

Since the Company has only one reportable segment, no additional segment disclosures are required beyond entity-wide disclosures presented below.

11 

NOCOPI TECHNOLOGIES, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

Entity-Wide Disclosures

 

  · Geographic Revenue Information: For both the three and six months ended June 30, 2025, 38% of the Company’s net sales were generated in North America and 62% internationally. For both the three and six months ended June 30, 2024, 19% of the Company’s net sales were generated in North America and 81% were generated internationally. Refer to Note 9.

 

  · Major Customers:. The Company had two and three customers that accounted for 82% and 83% of revenue for the three and six months ended June 30, 2025, respectively; and two customers that accounted for 89% of net accounts receivable for the quarter ended June 30, 2025. In addition, the Company had two customers that accounted for 83% and 84% of revenue for the three and six months ended June 30, 2024, respectively; and two customers that accounted for 93% of net accounts receivable as of December 31, 2024. Refer to Note 9.

 

Note 12. Subsequent Events – Enactment of Federal Tax Legislation

On July 2, 2025, subsequent to the end of the reporting period, U.S. Congress enacted the Taxpayer Fairness and Growth Act of 2025, which includes significant amendments to the Internal Revenue Code.

The Company is currently evaluating the impact of the legislation on its consolidated financial statements, including deferred tax assets and liabilities. Because the enactment occurred after the end of the reporting period and before issuance of these financial statements, the effects have not been recognized in the accompanying condensed consolidated financial statements as of and for the period ended June 30, 2025, consistent with ASC 740 and ASC 855.

The Company expects the corporate rate reduction to have a favorable impact on its effective tax rate beginning in fiscal 2026. However, remeasurement of deferred tax balances and the application of new limitations may result in non-cash tax charges in future periods. The Company will continue evaluating the impact and recognize any required adjustments in the period of enactment.

 

12 
 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Information

 

This Quarterly Report on Form 10-Q contains, and our officers and representatives may from time to time make, “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding:

 

  · Expected operating results, such as revenue, expenses and capital expenditures
  · Current or future volatility in market conditions
  · Our belief that we have sufficient liquidity to fund our business operations during the next twelve months
  · Strategy for customer retention, growth, product development, market position, and risk management

 

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

 

  · The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.
  · Strategic actions, including business acquisitions and our success in integrating acquired businesses.
  · Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.
  · The impact of losing our intellectual property protections or the loss in value of our intellectual property.
  · Changes in customer demand.
  · The occurrence of hostilities, political instability or catastrophic events.
  · Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.
  · Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.
  · Such other factors as discussed throughout Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q, and throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Part I, Item 1A. Risk Factors of the 2024 Annual Report.

 

 

13 
 

 

 

Any forward-looking statement made by us in this Quarterly Report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

The following discussion and analysis should be read in conjunction with our condensed financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management. This information should also be read in conjunction with our audited historical financial statements which are included in the Annual Report.

 

Background Overview

 

Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.

 

Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.

 

 Results of Operations

 

The Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.

 

The Company recognizes revenue on its lines of business as follows:

 

  a. License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;
  b. Product sales are recognized at the time of the transfer of goods to customers at an amount that the Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
  c. Fees for technical services are recognized at the time of the transfer of services to customers at an amount that the Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

 

We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.

 

Both the absolute amount of the Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on the Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when the Company agrees to revise such terms, revenues from the customer may be adversely affected.

 

14 
 

 

 

Revenues for the second quarter of 2025 were $360,000 compared to $459,000 in the second quarter of 2024, a decrease of $99,000, or approximately 22%. Licenses, royalties and fees increased by $51,100, or approximately 57%, to $140,100 in the second quarter of 2025 from $89,000 in the second quarter of 2024. The increase in licenses, royalties and fees in the second quarter of 2025 compared to the second quarter of 2024 is due primarily to higher royalties from the Company’s licensees in entertainment and toy products markets and a new licensee. We cannot assure you that the marketing and product development activities of the Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for the Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions presently being experienced.

 

Product and other sales decreased by $150,100, or approximately 41%, to $219,900 in the second quarter of 2025 from $370,000 in the second quarter of 2024. Sales of ink decreased in the second quarter of 2025 compared to the second quarter of 2024 due primarily to lower ink shipments to the third party authorized printer used by two of the Company’s major licensees in the entertainment and toy products market. In the second quarter of 2025, the Company derived revenues of approximately $301,300 from the Company’s licensees and their authorized printers in the entertainment and toy products market compared to revenues of approximately $424,800 in the second quarter of 2024.

 

 For the first six months of 2025, revenues were $839,000, representing a decrease of $18,300, or approximately 2%, from revenues of $857,300 in the first six months of 2024. Licenses, royalties and fees increased by $154,900, or approximately 88%, to $330,400 in the first six months of 2025 from $175,500 in the first six months of 2024. The increase in licenses, royalties and fees is due primarily to higher royalties from the Company’s licensees in the entertainment and toy products market, renewal of an existing licensee and a new licensee. We cannot assure you that the marketing and product development activities of the Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for the Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions presently being experienced.

 

Product and other sales decreased by $173,200, or approximately 25%, to $508,600 in the first six months of 2025 from $681,800 in the first six months of 2024. Sales of ink decreased in the first six months of 2025 compared to the first six of 2024 due primarily to lower ink shipments to the third party authorized printer used by two of the Company’s major licensees in the entertainment and toy products market. The Company derived revenues of approximately $631,500 from licensees and their authorized printers in the entertainment and toy products market in the first six months of 2025 compared to revenues of approximately $788,000 in the first six months of 2024.

 

The Company’s gross profit decreased to $191,500 in the second quarter of 2025, or approximately 53% of revenues, from $230,300 in the second quarter of 2024, or approximately 50% of revenues. Licenses, royalties and fees have historically carried a higher gross profit than product and other sales, which generally consist of supplies or other manufactured products which incorporate the Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by the Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees.

 

For the first six months of 2025, gross profit was $465,200, or approximately 55% of revenues, compared to $395,900, or approximately 46% of revenues, in the first six months of 2024. The higher gross profit in the first six months of 2025 compared to the first six months of 2024 was primarily due to an increase in gross profit from licenses, royalties and fees.

 

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both the gross profit from licenses, royalties and fees as well as overall gross profit. The gross profit from licenses, royalties and fees increased to approximately 72% in the second quarter of 2025 compared to approximately 43% in the second quarter of 2024 and to approximately 75% of revenues from licenses, royalties and fees in the first six months of 2025 from approximately 41% in the first six months of 2024.

 

 

15 
 

 

 

The gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. The gross profit from product and other sales decreased to approximately 41% of revenues in the second quarter of 2025 compared to approximately 52% of revenues in the second quarter of 2024. For the first six months of 2025, the gross profit, expressed as a percentage of revenues, decreased to approximately 43% of revenues from product and other sales compared to approximately 47% of revenues from product and other sales in the first six months of 2024

 

Research and development expenses increased in the second quarter of 2025 to $43,200 from $42,100 in the second quarter of 2024 and to $88,200 in the first six months of 2025 from $83,500 in the first six months of 2024 due primarily to higher lab expenses in the second quarter and first six months of 2025 compared to the second quarter and first six months of 2024.

 

Sales and marketing expenses decreased to $57,300 in the second quarter of 2025 from $75,900 in the second quarter of 2024 due primarily to lower commission and employee related expenses in the second quarter of 2025 compared to the second quarter of 2024. Sales and marketing expenses increased to $148,300 in the first six months of 2025 from $144,900 in the first six months of 2024 due primarily to lower commission expense on the lower level of revenues, higher lease expense and travel in the first six months of 2025 compared to the first six months of 2024. 

 

General and administrative expenses decreased in the second quarter and first six months of 2025 to $263,500 and $487,000, respectively, from $1,254,700 and $2,469,500, respectively due primarily to lower stock-based compensation, higher professional fees, and lower employee related expenses in the second quarter and first six months of 2025 compared to the second quarter and first six months of 2024.

 

For the second quarter of 2025, there was no income tax benefit for the net losses for the second quarter of 2025 due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. Income taxes in the second quarter of 2025 include federal and state income taxes. The state income taxes result from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

 

The net loss of $58,600 in the second quarter of 2025 compared to a net loss of $1,005,400 in the second quarter of 2024 resulted primarily from a higher gross profit on a higher level of licenses, royalties and fees and lower product sales, lower operating expenses and interest income in the second quarter of 2025 compared to the second quarter of 2024. The net loss of $33,100 in the first six months of 2025 compared to a net loss of $2,033,600 in the first six months of 2024 resulted primarily from a higher gross profit on a higher level of license, royalties, and fees and lower product sales in the first six months of 2025 compared to the first six months of 2024, lower operating expenses and interest income in the first six months of 2025 compared to the first six months of 2024.

 

Plan of Operation, Liquidity and Capital Resources

 

During the first six months of 2025, the Company’s cash increased to $11,295,000 at June 30, 2025 from $10,839,700 at December 31, 2024. During the first six months of 2025, the Company generated $455,300 from its operating activities.

 

During the first six months of 2025, the Company’s revenues decreased approximately 2% primarily as a result of lower sales of ink to an authorized printer of the Company’s licensees in the entertainment and toy products market and higher royalty revenues from the Company’s licensees in the entertainment and toy products market. Our total overhead expenses decreased in the first six months of 2025 to $723,500 compared to $2,697,900 in the first six months of 2024, and the Company’s interest income decreased in the first six months of 2025 compared to the first six months of 2024. As a result of these factors, the Company generated a net loss of $33,100 in the first six months of 2025 compared to a net loss of $2,033,600 in the first six months of 2024. The Company had positive operating cash flow of $455,300 during the first six months of 2025. At June 30, 2025, the Company had positive working capital of $12,400,700 and stockholders’ equity of $13,610,800. For the full year of 2024, the Company had a net loss of $2,678,900 and had positive operating cash flow of $594,800. At December 31, 2024, the Company had working capital of $12,388,300 and stockholders’ equity of $13,639,800.

 

 

16 
 

 

 

Our plan of operation for the twelve months beginning with the date of this Quarterly Report on Form 10-Q consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships the Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating the Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with the Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.

 

The Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable the Company to generate additional revenues and positive cash flow.

 

Our future growth strategy includes expanding our business through acquisitions of other companies with competing or complementary services, technologies or businesses in order to expand our product and service offerings to grow our free cash flow. We are currently actively engaged in the process to identify acquisition candidates and negotiate transactions. As of the date of this Quarterly Report on Form 10-Q, we have no agreements to make any acquisition. We expect to fund our business expansion through the issuance of debt or equity securities, the payment of cash, the exchange of services, or any combination thereof.

The Company has received, and may in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirements and to provide funding for other business opportunities. We cannot assure you that if we require additional capital, that we will be successful in obtaining such additional capital, or that such additional capital, if obtained, will enable the Company to generate additional revenues and positive cash flow.

 

As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment in 2025 and beyond and its effect on the global economy, geopolitical instability including the Russia-Ukraine war and conflicts in the Middle East and the supply chain disruptions related to both as well as the record inflation and significantly higher interest rates currently being experienced in the United States along with the probability of an economic recession both in the United States and globally. As a result, our revenues, results of operations and liquidity may be further negatively impacted in future periods.

 

Contractual Obligations

 

As of June 30, 2025, there were no material changes in our contractual obligations from those disclosed in the 2024 Annual Report, other than those appearing in the notes to the financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

 

Recently Adopted Accounting Pronouncements

 

As of June 30, 2025 and for the period then ended, there are no recently adopted accounting standards that have a material effect on the Company’s financial statements.

 

 

17 
 

 

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

As of June 30, 2025, there were no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements.

  

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not Applicable

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of June 30, 2025. Based on this evaluation, the Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of June 30, 2025, the Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 

18 
 

 

  

PART II - OTHER INFORMATION

  

Item 1. Legal Proceedings.

 

None

 

Item 1A. Risk Factors.

 

Information about risk factors for the quarter ended June 30, 2025 does not differ materially from that set forth in Part I, Item 1A of the 2024 Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not applicable

 

Item 5.  Other Information.

 

From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend or terminate written trading arrangements pursuant to Rule 10b5-1 of the Securities and Exchange Act or otherwise.

 

For the quarter ended June 30, 2025, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.

 

Item 6.  Exhibits.

 

(a) Exhibits

  

Exhibit Number   Description   Location
31.1   Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith
31.2   Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith
32.1   Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Furnished herewith
101.INS   Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document    
101.SCH   Inline XBRL Taxonomy Extension Schema    
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase    
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase    
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase    
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase    
104   Cover page formatted as Inline XBRL and contained in Exhibit 101    

 

 

19 
 

 

 

SIGNATURES

 

Pursuant to the requirement of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    NOCOPI TECHNOLOGIES, INC.
     
DATE: August 11, 2025   /s/ Matthew C. Winger
    Matthew C. Winger
    Chairman of the Board & Chief Executive Officer (Principal Executive Officer)
     
DATE: August 11, 2025   /s/ Debra E. Glickman
    Debra E. Glickman
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

20